Diagnos Inc DGNOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.24
- Day Range
- $0.22–0.24
- 52-Week Range
- $0.18–0.43
- Bid/Ask
- $0.19 / $0.24
- Market Cap
- $19.18 Mil
- Volume/Avg
- 27,000 / 41,793
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 136.27
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 16
- Website
- http://www.diagnos.ca
Valuation
|
Metric
|
DGNOF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 136.27 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
DGNOF
|
|---|---|
Quick Ratio | 0.23 |
Current Ratio | 0.25 |
Interest Coverage | −4.68 |
Quick Ratio
DGNOF
Profitability
|
Metric
|
DGNOF
|
|---|---|
Return on Assets (Normalized) | −323.75% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −601.40% |
Return on Assets
DGNOF
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock
GEHC
| Btgqktkz | Whgx | $36.7 Bil | |||
| Veeva Systems Inc Class A
VEEV
| Zrstqtdv | Sfpg | $31.1 Bil | |||
| Solventum Corp
SOLV
| — | Ptytz | $10.0 Bil | |||
| Pro Medicus Ltd
PMCUF
| — | Rddkr | $9.2 Bil | |||
| HealthEquity Inc
HQY
| — | Fqnjt | $7.0 Bil | |||
| Tempus AI Inc Class A common stock
TEM
| — | Rnlj | $6.9 Bil | |||
| M3 Inc
MTHRF
| — | Rtmfkfl | $6.6 Bil | |||
| M3 Inc ADR
MTHRY
| — | Ykdsk | $6.6 Bil | |||
| R1 RCM Inc
RCM
| — | Qgwlk | $5.5 Bil | |||
| Doximity Inc Class A
DOCS
| — | Ctwnyk | $5.2 Bil |